Vaxin, Inc. Awarded Biomedical Advanced Research and Development Authority (BARDA) Contract Valued at up to $21.7 Million to Develop Next Generation Anthrax Vaccine
9/19/2011 6:46:51 AM
More...
|
Vaxin, Inc. Receives Birmingham Business Journal’s "Pacesetter" Award
4/30/2010 1:16:02 PM
More...
|
Biotech Firm Vaxin, Inc. Taps New CEO, Looks for VC Funds
8/8/2008 7:00:28 AM
More...
|
Birmingham Biotech Vaxin, Inc. Heading to Asia
5/4/2007 12:28:40 PM
More...
|
Auburn University Researcher Develops Avian Flu Vaccine For Poultry
1/3/2007 11:39:50 AM
More...
|
Data From Vaxin, Inc.'s First Flu Vaccine Clinical Trial Reported In Journal "Vaccine"
10/19/2005 5:12:07 PM
More...
|
Revolutionary Flu Vaccine In Development By Vaxin, Inc.
10/19/2005 5:11:47 PM
More...
|
Crucell N.V. (CRXL) And Vaxin, Inc. Announce PER.C6 Licensing Agreement
10/19/2005 5:10:08 PM
More...
|
International Vaccine Expert Dr. Alf Lindberg Joins Vaxin, Inc. Board Of Directors
10/19/2005 5:08:58 PM
More...
|